Community Medicine Seminar Series
Biodefense, Social Justice and the Ecological Imagination in Public Health
Lisa A. Eckenwiler, Ph.D.
†
Associate Professor of Philosophy
Old Dominion University
Wednesday, May 25, 2005 • 12:00 - 1:30 PM
Academic Research Building, Large Conf. Room (EG-013)
University of Connecticut Health Center
For lunch, please RSVP by May 23, 2005 to Theo Ungewitter at 860.679.5495.
About the Speaker
Lisa Eckenwiler, Ph.D. is Associate Professor of Philosophy and Co-Director
of the Institute for Ethics and Public Affairs at Old Dominion University
where she teaches bioethics, ethics in public health, and other courses in
moral philosophy. She earned her Ph.D. in philosophy with a concentration
in bioethics at the University of Tennessee Knoxville, her B.A. at the University
of Wisconsin-Madison, and carried out a summer fellowship in clinical ethics
and cultural pluralism at the University of Texas Health Sciences Center at
San Antonio. Before her appointment at Old Dominion, Professor Eckenwiler
taught at the University of Illinois at Chicago, and Loyola University, Stritch
School of Medicine. She served as Director of the Consortium to Examine Clinical
Research Ethics, a nationwide, multidisciplinary effort to assess policy in
research ethics based at Duke University Medical Center. Her work has focused
on a wide array of ethical issues in research involving human subjects, access
to AIDS care, law and policy concerning pregnant addicts, and the ethical
obligations of emergency health workers in crisis. Currently, she is working
on a book, The Ethics of Bioethics: Mapping the Moral Landscape (forthcoming
from Johns Hopkins University Press). Other research projects include the
ethical implications for public health of biodefense policy, and justice and
caregiving for the elderly in the context of globalization. She is also serving
as Co-chair of the 2005 Annual Meeting of the American Society for Bioethics
and Humanities.
† - Dr. Eckenwiler is a candidate for the Joseph M. Healey Endowed Chair in the Medical Humanities, Law & Bioethics
About the Educational Activity
Target Audience
Physicians and Other Health Professionals, Medical and Dental Students, Faculty
Objectives
At the end of this presentation, participants will:
- Learn specific arguments made in support of Biodefense and emergency preparedness initiatives.
- Understand ethical concerns raised regarding these initiatives, above all concerns of social justice.
- Explore the epistemological roots of policy in Biodefense and emergency preparedness.
- Consider an alternative epistemological model which promises more explanatory power and which better promotes ethical ideals, chiefly social justice, in public health.
Accreditation
The Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians accredits The University of Connecticut School of Medicine. The University of Connecticut School of Medicine takes responsibility for the content, quality and scientific integrity of this CME activity.
The University of Connecticut School of Medicine designates this educational activity for a maximum of 1.5 hours per session in category 1 credit towards the AMA Physician’s Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
Conflict of Interest
All faculty participating in Continuing Medical Education activities sponsored
by the University of Connecticut School of Medicine are required to disclose
to the program audience any real or apparent conflict of interest related
to the content of
their presentations. Dr. Eckenwiler does not have a financial interest/arrangement
or affiliation with any organizations that could be perceived as a real or
apparent conflict of interest in the context of the subject of his presentation,
nor will he address any unlabeled use for a drug in this presentation.
Sponsors
University of Connecticut School of Medicine Office of Continuing Education, Department of Community Medicine and supported in part by an unrestricted educational grant from Agouron Pharmaceuticals, Inc.